TYK2 inhibition may offer new strategy to reduce tau toxicity in Alzheimer’s

  • Post author:
  • Post category:uncategorized

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital and collaborating institutions discovered that the enzyme TYK2 transforms the normal protein tau into one that accumulates in the brain and contributes to the development of Alzheimer’s disease in animal models.